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Background: We sought to determine the extent to which physicians agree about the appropriate decision
threshold for recommending magnetic resonance imaging in a clinical practice guideline for children with recurrent
headache.
Methods: We surveyed attending physicians in Canada practicing in community pediatrics, child neurology,
pediatric radiology, and pediatric neurosurgery. For children in each of six risk categories, physicians were asked to
determine whether they would recommend for or against routine magnetic resonance imaging of the brain in a
clinical practice guideline for children with recurrent headache.
Results: Completed surveys were returned by 114 physicians. The proportion recommending routine neuroimaging
for each risk group was 100% (50% risk), 99% (10% risk), 93% (4% risk), 54% (1% risk), 25% (0.4% risk), 4% (0.01% risk).
Community pediatricians, physicians in practice >15 years, and physicians who believed they ordered neuroimaging
less often than peers were less likely to recommend neuroimaging for the 1% risk group (all p < 0.05).
Conclusions: There is no consensus among pediatric specialists regarding the appropriate decision threshold for
neuroimaging in a clinical practice guideline for children with recurrent headache. Because of the impact that
individual threshold preferences may have on guidelines, these findings support the need for careful composition
of guideline committees and consideration of the role of patient and family preferences. Our findings also support
the need for transparency in guidelines regarding how evidence was translated into recommendations and how
conflicts were resolved.
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Variable recommendations for breast cancer screening
among countries and organizations demonstrate the
complexity of translating evidence into recommendations,
even in very well-studied conditions [1-4]. Disagreement
can arise over a variety of issues, including which studies
provide sufficiently valid evidence to be included in
analysis, the relative value of various outcomes, and the
degree to which personal preferences of patients and
families should be considered [5-9]. Another issue which* Correspondence: cdaymont@mich.ca
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unless otherwise stated.may cause disagreement is the decision threshold: the
level of risk above which testing or treatment should take
place, and below which it is unnecessary [10-12].
Identification of the risk threshold for testing or
treatment generally involves subjective judgment [13].
In some situations, decision analysis may help to
identify an appropriate threshold. However, valid and
reliable input required to obtain a valid and reliable
result from decision analysis is unavailable for many
conditions. Even when data are available, determining
which outcomes should be considered in decision
analysis, and how costs should be considered, involves
some personal judgment. In practice, identification of
a threshold may be entirely dependent on personal
judgment, particularly for conditions with a relativelyal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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disease and effects of treatment. This dependence on
personal judgment may contribute to variability in the
practice of individual physicians as well as variability
in recommendations of clinical practice guidelines
produced about the same topic.
Thresholds for action are an important part of clinical
prediction rules. Clinical prediction rules are sometimes
able to identify groups of patients with very high or low
levels of risk for which the appropriate recommendation
is clear. However, some groups of patients identified by
a clinical prediction rule may have a degree of risk
for which there is no consensus about the appropriate
recommendation. For example, in a recent clinical
prediction rule for identifying intracranial pathology
in children with minor head trauma, approximately
30% of children in the study were found to have a
combined risk of 0.9% for intracranial pathology [14].
The clinical prediction rule publication recommended
making decisions based on individual factors for children
in this intermediate-risk category.
In this study, we sought to explore the variability
among physicians regarding decision thresholds. We
performed a survey to identify the degree of consensus
among physicians from relevant specialties about the
appropriate threshold for neuroimaging in children
with recurrent headache when forming a clinical practice
guideline based on a clinical prediction rule. We also
sought to explore physician characteristics that may
be associated with recommendations for or against
neuroimaging at a given risk level.
Methods
Survey design
No validated tools were identified to address our questions;
therefore, a survey was developed by the research
team. The survey was refined through two pilot
surveys, administered to twelve physicians each, with
three physicians contributing to both pilot surveys.
The survey was administered via SurveyMonkey (Palo
Alto, California) (Additional file 1).
We aimed to evaluate thresholds using a method that
would best approximate decisions made during clinical
practice guideline development. Participants were asked
to respond as if they were part of a committee developing
clinical practice guidelines for children with recurrent
headaches based on a hypothetical, well-validated
clinical prediction rule. Participants were advised that
follow-up would be recommended regardless of the
recommendation regarding neuroimaging. Participants
were asked to indicate whether they believed magnetic
resonance imaging should be recommended or not
recommended for children in each of six risk categories:
50% (1/2), 10% (1/10), 4% (1/25), 1% (1/100), 0.4% (1/250)and 0.01% (1/10,000). The risk categories were chosen
based on the pilot surveys, as well as a retrospective study
of risk of pathology in children with headache and an
associated cost-effectiveness analysis [15,16]. Participants
were not provided with any corresponding clinical features
for the hypothetical risk levels. An extremely high and an
extremely low level of risk at which we expected no
disagreement were included. Participants were also
asked whether they would be willing to change their
recommendation for the 1% risk group to achieve
consensus if everyone else on the committee had chosen
the opposite recommendation.
The final page of the survey included thirteen statements
of beliefs about neuroimaging framed within the Theory of
Planned Behavior [17-20]. Participants were asked to rate
their level of agreement with the statements using a
7-point Likert scale. We initially identified 51 beliefs
related to neuroimaging decisions based on literature and
discussions with colleagues. In the interest of keeping
the survey brief, we eliminated beliefs for which we
anticipated a high degree of agreement, and included
13 belief statements in the final survey. The survey
also included questions about advanced epidemiology
training, participation in clinical practice guideline
development, and the participants’ perception of his or her
own neuroimaging ordering frequency compared to peers.
Participants
The population of interest was physicians in Canada
who are commonly involved in the care of children
with recurrent headache or the pathology with which
it may be associated. Attending physicians who were
in active practice in one of the following four specialties
were eligible for inclusion: community pediatricians,
child neurologists, pediatric radiologists, and pediatric
neurosurgeons.
Some community pediatricians in Canada practice
primary care, although most see patients referred from
family physicians. Two family physicians were included
in the initial pilot, and both indicated that they would
generally defer decisions about neuroimaging in children
to pediatricians.
Recruitment
Pediatric neurosurgeons were contacted through the
email distribution list of the Canadian Pediatric
Neurosurgery Study Group. Community pediatricians
were contacted through the email distribution list for
the Section of Community Pediatrics of the Canadian
Pediatric Society. Pediatric radiologists were contacted
through the Society for Pediatric Radiology. Child
neurologist contact information was identified through
publically available sources, and each was contacted
individually. Review of the contact list by a Canadian
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majority of attending Canadian child neurologists.
Each participant was contacted by email three times,
at varying times and days of the week. The emails were
sent 1–2 weeks apart. The tone and length of the emails
also varied [21]. No monetary incentive was offered. No
identifying personal information was collected except for
an option to provide an email address in order to ask
questions or request a copy of the results.
Analysis
The primary outcome was the proportion of participants
who would recommend neuroimaging for each risk
category. The recommendation for the 1% risk category
was used for further analysis because the highest level of
disagreement was anticipated for this category. Fisher’s
exact test was used to evaluate the association of eight
physician characteristics and thirteen neuroimaging
beliefs with the recommendation for the 1% risk
category. Belief answers were converted to binary
measures by combining all disagree and neutral answers
in one category, and all agree answers in the other
category. A p-value of 0.05 was used to determine
statistical significance without a correction for multiple
comparisons, as these analyses were exploratory and
primarily for the purpose of hypothesis generation.
Nonresponders and missing data
In order to evaluate for possible nonresponse bias,
responses of physicians who responded to the first
notice were compared with physicians who responded to
the second or third notice [22]. The characteristics of
physicians who did not respond to the primary question
were also compared with the characteristics of those who
responded fully.
Ethics
Administration of the survey, and pilot surveys, was
reviewed and approved by the Health Research Ethics
Board at the University of Manitoba. The survey includedTable 1 Response and question completion rates, overall and
Overall Pediatric neurosurgeons C
Total # initially contacted 432 31 84
# (%) responded 152 26 33
(35%) (84%) (3
# respondents eligible 132 24 30




# (%) completed last question 115 22 27
(87%) (92%) (9a consent disclosure statement on the first electronic page
(Additional file 1).Results
Responses
The survey was administered between October 2011 and
February 2012. The overall response rate for the survey
was 35% (Table 1). The response rate varied by specialty.
Pediatric neurosurgeons had a response rate of 84%.
Pediatric neurosurgeons were relatively few in number
and were contacted by one of the authors, who is also a
colleague.Recommendations
No respondent had conflicting recommendations, defined
as recommending neuroimaging for a group with a lower
risk than a group for which they had recommended
against neuroimaging.
For children with recurrent headache and a 1% risk of
treatable pathology, 54% of surveyed physicians recom-
mended routine neuroimaging and 46% recommended
against routine neuroimaging (Table 2). Forty-five percent
of the respondents indicated they would be willing to
change their response for the 1% risk group in order
to achieve consensus with the guideline committee.
Respondents who recommended for neuroimaging in the
1% risk group were less likely to be willing to change their
answer than those recommending against neuroimaging
(33% v 58%, p = 0.008 using Fisher’s exact test).
For the next-lowest risk category (0.4% risk) 25% of
participants recommended routine neuroimaging. A
small proportion of respondents (4%) recommended
routine neuroimaging for patients in the lowest risk
group (0.01% risk).
Most participants (93%) recommended routine neuroim-
aging for children with a 4% risk. All but one respondent
recommended routine neuroimaging for children with a
10% risk of treatable pathology, and all recommended
routine neuroimaging for children with a 50% risk of
treatable pathology.by specialty









Table 2 Recommendations for neuroimaging for each risk group, overall and by specialty
Risk group Percent and number recommending neuroimaging
Overall Pediatric neurosurgeons Child neurologists Pediatric radiologists Community pediatricians
50% 100% 100% 100% 100% 100%
116/116 23/23 26/26 11/11 56/56
10% 99% 96% 100% 100% 100%
114/115 22/23 26/26 11/11 55/55
4% 93% 95% 96% 100% 89%
107/115 21/22 25/26 11/11 50/56
1%* 54% 67% 65% 73% 39%
61/114 14/21 17/26 8/11 22/56
0.4% 25% 23% 37% 36% 18%
29/116 5/22 10/27 4/11 10/56
0.01% 4% 0% 8% 9% 4%
5/113 0/22 2/24 1/11 2/56
*Denotes association of recommendation with specialty (p < 0.05 using Fisher’s exact test).
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characteristics and beliefs
Three of the eight tested characteristics were significantly
(p < 0.05) associated with recommendation for the 1% risk
group (Table 3). Those in practice more than 15 years
were less likely than those in practice fewer than 15 years
to recommend neuroimaging (41% v. 63% p = 0.023).
Community pediatricians were less likely than subspecial-
ists to recommend neuroimaging (39% v. 67%, p = 0.005).Table 3 Association of physician characteristics with recomm
Physician characteristic Response T
#




Years in practice 15 or less 5
More than 15 5
Practice type Academic 8
Community 3
Practice location Urban/suburban 9
Rural 1
Advanced epidemiology training Yes 1
No 9
Participation in guideline production Yes 6
No 4
Self-assessment of imaging frequency Less often than peers 4
More often or same 6
Two by two tables comparing characteristics with recommendation are presented a
1% group = recommended routine neuroimaging for the 1% risk group; Rec no NI f
risk group.The response of community pediatricians did not vary
by type of community practice (primary care versus
consultant). Those physicians who believed that they
ordered neuroimaging less often than their colleagues
were less likely to recommend neuroimaging than
those who believed they ordered neuroimaging at
least as often as colleagues (35% v. 63%, p = 0.006).
A high degree of variability was seen in the level of
agreement for some of the belief statements, particularlyendation for 1% risk group
otal # (%) # (%) Fisher’s exact
testRec NI for 1% Rec no NI for 1%
6 22 (39%) 34 (61%)
8 39 (67%) 19 (33%) p = 0.005*
2 33 (53%) 29 (47%)
0 26 (52%) 24 (48%) p = 1.000
7 36 (63%) 21 (37%)
4 22 (41%) 32 (59%) p = 0.023*
2 47 (57%) 35 (43%)
2 14 (44%) 18 (56%) p = 0.215
9 55 (56%) 44 (44%)
5 6 (40%) 9 (60%) p = 0.281
7 11 (65%) 6 (35%)
6 49 (51%) 47 (49%) p = 0.430
9 37 (54%) 32 (46%)
5 24 (53%) 21 (47%) p = 1.000
3 15 (35%) 28 (65%)
7 42 (63%) 25 (37%) p = 0.006*
long with p-values using Fisher’s exact test (<0.05 marked with *). Rec NI for
or 1% group = recommended against routine neuroimaging for the 1%
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and preferences regarding neuroimaging and the degree
to which those factors should be taken into account
when making decisions about neuroimaging (Table 4).
There were no significant associations between agreement
with any of the belief statements and recommendation
for the 1% risk group. There were also no significant
associations between the evaluated physician characteris-
tics or beliefs and willingness to change response in order
to achieve consensus.
We evaluated the 13 respondents with uncommon
recommendations, including 5 who recommended for
neuroimaging in the 0.01% risk group and 8 who
recommended against neuroimaging in the 4% risk
group (including 1 who also recommended against
neuroimaging in the 10% risk group). Physicians withTable 4 Association of physician beliefs about neuroimaging
Belief
It would be possible to develop a clinical prediction rule that accurately
determines risk for children with recurrent headaches.
Neuroimaging is uncomfortable for many children.
Patient comfort should be considered when making decisions about
neuroimaging.
Recommending neuroimaging is likely to cause anxiety for the patient
or family.
Recommending against neuroimaging is likely to cause anxiety for the
patient or family.
Patient and caregiver anxiety should be considered when making
decisions about neuroimaging.
The monetary cost to society should be considered when making
decisions about neuroimaging.
Caregivers of patients with recurrent headaches expect me to order
neuroimaging.
Patient or caregiver preferences should be considered when making
decisions about neuroimaging.
A delay in diagnosis leads to significant negative consequences for physician
My colleagues believe it is important to avoid unnecessary neuroimaging.
I am able to convince caregivers to agree with my point of view regarding
whether their child should receive neuroimaging.
I am able to determine which children require neuroimaging.
Two by two tables comparing agreement with the belief with the recommendation
<0.05). Rec NI for 1% group = recommended routine neuroimaging for the 1% risk
for the 1% risk group.outlying responses of either type did not share any
uncommon characteristics or beliefs. All 5 respondents
who recommended for neuroimaging in the 0.01% risk
group indicated that they did believe it was possible for a
clinical prediction rule to accurately predict risk. Ten of
13 (77%) of these respondents with uncommon responses
would not have agreed to change their answer for children
with a 1% risk in order to achieve consensus.
Late and incomplete responders
Physicians who responded to the first survey invitation
were more likely to recommend neuroimaging for
children with a 1% risk compared to physicians who
responded to subsequent survey invitations (63% v 42%,
Fisher’s exact p = 0.04). Physicians who responded to the
first versus second or third survey invitations did notwith recommendation for 1% risk group
Response Total
#





Agree 97 54 (56%) 43 (44%)
Neutral/Disagree 17 7 (41%) 10 (59%) p = 0.302
Agree 66 32 (48%) 34 (52%)
Neutral/Disagree 48 29 (60%) 19 (40%) p = 0.255
Agree 63 39 (62%) 24 (38%)
Neutral/Disagree 51 22 (43%) 29 (57%) p = 0.059
Agree 70 36 (51%) 34 (49%)
Neutral/Disagree 44 25 (57%) 19 (43%) p = 0.700
Agree 73 42 (58%) 31 (42%)
Neutral/Disagree 41 19 (46%) 22 (54%) p = 0.328
Agree 66 34 (52%) 32 (48%)
Neutral/Disagree 48 27 (56%) 21 (44%) p = 0.705
Agree 82 43 (52%) 39 (48%)
Neutral/Disagree 32 18 (56%) 14 (44%) p = 0.835
Agree 62 37 (60%) 25 (40%)
Neutral/Disagree 52 24 (46%) 28 (54%) p = 0.188
Agree 59 35 (59%) 24 (41%)
Neutral/Disagree 55 26 (47%) 29 (53%) p = 0.260
s. Agree 95 52 (55%) 43 (45%)
Neutral/Disagree 19 9 (47%) 10 (53%) p = 0.620
Agree 96 48 (50%) 48 (50%)
Neutral/Disagree 18 5 (28%) 13 (72%) p = 0.122
Agree 103 55 (53%) 48 (47%)
Neutral/Disagree 11 6 (55%) 5 (45%) p = 1.000
Agree 108 57 (53%) 51 (47%)
Neutral/Disagree 6 4 (67%) 2 (33%) p = 0.684
are presented along with p-values using Fisher’s exact test (no p-values were
group; Rec no NI for 1% group = recommended against routine neuroimaging
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characteristics, agreement with belief statements, or
willingness to change response in order to achieve
consensus.
Eighteen of the 132 eligible respondents did not
answer the primary question of interest regarding the
recommendation for the 1% risk group. There were two
physician characteristics associated with an increased
likelihood of providing a response to the primary survey
question regarding the recommendation for children
with a 1% risk. Community pediatricians were more
likely than specialists to answer the 1% question (93% v.
81%, p = 0.03), and those in community settings were
more likely to answer the 1% risk question than those in
academic settings (97% v 83%, p = 0.03).
Comments
Several respondents mentioned in free text comments that
it was difficult to answer some of the belief questions
because they were dependent on circumstances. For
example, a physician noted that if a child has a very
high risk of pathology, parent preferences should not
be considered but that in a patient with lower risk,
parent preferences should be taken into account.
Discussion
There is substantial disagreement among pediatric
specialists regarding the appropriate recommendation
for children with recurrent headache and a 0.4% or
1% of treatable pathology. Community pediatric practice,
more than 15 years in practice, and self-perception of
ordering neuroimaging less often than peers were
significantly associated with a decreased likelihood to
recommend routine neuroimaging for children with a
1% risk of treatable pathology. Respondents were mixed re-
garding their willingness to adjust their recommendations
in order to achieve consensus with a guideline committee.
More research regarding the risks and benefits of
neuroimaging in this population would potentially
improve our ability to identify the best threshold for
neuroimaging in children with recurrent headache,
but some issues crucial for effective formal decision
analysis will likely never be resolved. Most importantly,
we will almost certainly never be able to quantify the
impact of delayed diagnosis on the long-term outcomes
of children with intracranial pathology who present
with headache.
Our findings indicate that recommendations for
children with intermediate degrees of risk may be
strongly influenced by characteristics and beliefs of
individual guideline committee members, particularly
their beliefs about appropriate decision thresholds and
the strengths of these beliefs. These findings provide
support for recommendations from the Institute ofMedicine and others for guidelines to include information
about the methods for translating evidence into recom-
mendations and also to describe how conflicts were
resolved [5,23,24].
The findings also support recommendations that
guideline development committee members should include
a diverse representation of health care professionals in
addition to other stakeholders [5,23-25]. Including
physicians with variable durations of practice and ensuring
representation from both academic and community
practice may be factors to consider when evaluating
the diversity of a committee. It may also be appropriate to
consider identifying members with varied self-perceptions
of practice style. Some organizations producing guidelines
may even wish to consider more explicit evaluations or
discussions regarding the decision threshold preferences
of potential committee members. Organizations producing
guidelines may want to insure that those with less common
views are included on guideline committees. Others may
feel that certain views about thresholds do not represent
the values of the organization or that physicians with less
common views would have a disproportionate impact on
the recommendations.
Particularly when there is a lack of consensus among
health care professionals regarding the appropriate recom-
mendation, universal recommendations in a guideline may
not be appropriate [23,26-28]. Our findings support the
use of explicit discussions in guidelines regarding the role
of patient and family preferences, as demonstrated in
clinical practice guidelines recently produced by the
American Academy of Pediatrics [29-32].
Our study had limitations, including a response rate of
35%. This low response rate is of particular interest
because physicians who responded earlier were more
likely to recommend neuroimaging for the 1% group
than physicians who responded later, indicating possible
nonresponse bias. However, our primary conclusion
indicating disagreement among physicians regarding the
appropriate recommendation for children with recurrent
headache and a 1% risk of treatable pathology would very
likely remain true even with a large degree of non-response
bias. We identified no other differences in physician
characteristics or beliefs between early and late responders,
including no difference in the rate of participation in
guideline production. It is possible that timing of response
may be associated with some important characteristics that
we did not evaluate, or for which we did not have the
power to detect a difference.
Other limitations include that we only surveyed
physicians, and we only surveyed those practicing in
Canada. We did not do any repeat testing to determine
the reliability of recommendations or agreement with
beliefs. In future studies, we would ask respondents how
often they would agree with a belief rather than how
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dents in free-text comments. We only presented the risk
of treatable pathology, but many physicians may make
decisions based on the risk of any pathology, even if it is
not treatable [33]. We presented the risk in two formats
simultaneously, and did not evaluate alternate methods of
presenting the degree of risk. Physician responses to the
survey may or may not reflect decisions they would make
in real life. The fact that physicians’ self-assessment of their
imaging frequency compared to their peers were signifi-
cantly associated with their recommendations is one indica-
tion that disagreement regarding appropriate thresholds in
the survey answers may reflect real-world behavior.
No association was present between recommendations
and beliefs based on constructs from the Theory of
Planned Behavior. This may have resulted from a lack of
power to detect important differences, the way we asked
about beliefs, or a true lack of association between these
beliefs and decision thresholds in this context. In the
interest of keeping the survey brief, we did not explore
other factors that may affect decision thresholds, such
as physician risk preference or risk tolerance, which
have been shown to have variable associations with
decision-making [34-40].Conclusion
There is no consensus among pediatricians and pediatric
subspecialists in Canada regarding the appropriate
neuroimaging recommendation for children with a 1%
risk of intracranial pathology. More evidence regarding the
risks of neuroimaging and the benefit of early identification
of pathology may help to guide further recommendations,
but more evidence is unlikely to resolve the variability
completely. Further research into factors that affect
physician decision thresholds and other factors that
drive variability in guideline production and individual
physician decision-making could lead to improvements in
the guideline production process and provide information
to researchers who hope to develop the evidence that
supports guidelines. Organizations planning to produce
clinical practice guidelines should anticipate differing
opinions regarding the translation of evidence into guide-
lines due to variable decision thresholds and should
ensure transparency regarding the methods used to select
committee members, to determine the content and
strength of recommendations, and to resolve conflicts.Additional file
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